Inmune Bio Inc. (INMB)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
1. 57
-0.08
-4.8485%
$
50.25M Market Cap
- P/E Ratio
- Div Yield
196,200 Volume
-2.19 Eps
$ 1.65
Previous Close 
Want to track INMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Inmune Bio Inc. (INMB) Statistics
Valuation metrics
Market Cap 50.25M
Enterprise value 33.24M
Trailing P/E (ttm) -2.74
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) -
Price/Book (mrq) 2.48
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.82
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 216.2K
Average volume (90 days) 322.54K
Price summary
52-Week low 1.09
52-Week high 2.6
Beta -
50-Day moving average 1.93
200-Day moving average 1.45
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.69%
Return on equity -0.83%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.69
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.69
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 4.04%
Book value per share (mrq) 0.76
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
